BioScale's Series E Round

BioScale raised a round of funding on July 08, 2013.

BioScale develops, manufactures and promotes a protein measurement technology to accelerate drug discovery, development and production of biological and pharmaceutical products. The company enables cu…

Articles about BioScale's Series E Round: